All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ALLOGENE THERAPEUTICS, INC. Last Reported: 7/31/2021 Stock Symbol: ALLO

Business Address

210 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA US 94080

Mailing Address

210 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA US 94080
Phone Number: (650) 457-2700 / State Incorporated: / Fiscal Year End 12/31

Balance Sheet

Date 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017
Cash and Cash Equivalents $223,503,000.00 $236,865,000.00 $183,351,000.00 $158,136,000.00 $280,379,000.00 $135,897,000.00 $175,126,000.00 $160,990,000.00 $112,584,000.00 $92,748,000.00 $92,432,000.00 $83,141,000.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $14,464,000.00 $16,480,000.00 $17,220,000.00 $13,036,000.00 $9,927,000.00 $11,491,000.00 $14,043,000.00 $8,513,000.00 $9,118,000.00 $10,487,000.00 $8,598,000.00 $3,132,000.00 -- -- --
Total Current Assets $602,171,000.00 $716,061,000.00 $845,130,000.00 $854,058,000.00 $909,577,000.00 $504,414,000.00 $544,576,000.00 $509,757,000.00 $511,542,000.00 $476,627,000.00 $467,982,000.00 $247,353,000.00 -- -- --
Property Plant and Equipement $125,459,000.00 $123,146,000.00 $118,840,000.00 $102,653,000.00 $84,605,000.00 $66,349,000.00 $56,449,000.00 $45,943,000.00 $35,817,000.00 $20,426,000.00 $8,595,000.00 $4,693,000.00 -- -- --
Intangible Assets Net -- -- -- -- -- -- $151,000.00 $301,000.00 $452,000.00 $603,000.00 $754,000.00 $904,000.00 -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $5,829,000.00 $6,275,000.00 $5,169,000.00 $2,274,000.00 $2,160,000.00 $4,675,000.00 $4,618,000.00 $3,105,000.00 $2,238,000.00 $432,000.00 $244,000.00 $2,307,000.00 -- -- --
Total Assets $1,126,724,000.00 $1,179,044,000.00 $1,227,829,000.00 $1,222,500,000.00 $1,258,544,000.00 $688,523,000.00 $717,802,000.00 $695,544,000.00 $733,997,000.00 $749,369,000.00 $773,855,000.00 $435,235,000.00 -- -- --
Accounts Payable $11,005,000.00 $14,875,000.00 $10,390,000.00 $10,151,000.00 $9,057,000.00 $7,199,000.00 $9,250,000.00 $8,047,000.00 $23,503,000.00 $12,976,000.00 $12,338,000.00 $3,083,000.00 -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $102,912,000.00 $109,265,000.00 $148,212,000.00 $103,769,000.00 $95,125,000.00 $82,004,000.00 $88,779,000.00 $75,828,000.00 $78,362,000.00 $68,141,000.00 $70,691,000.00 $192,626,000.00 -- -- $2,000.00
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $1,774,298,000.00 $1,749,097,000.00 $1,725,552,000.00 $1,695,411,000.00 $1,673,026,000.00 $1,055,386,000.00 $1,023,876,000.00 $952,820,000.00 $937,709,000.00 $922,816,000.00 $914,265,000.00 $12,693,000.00 -- -- --
Accumulated Other Comprehensive Loss $-334,000.00 $-101,000.00 $268,000.00 $953,000.00 $1,830,000.00 $1,610,000.00 $1,145,000.00 $1,866,000.00 $2,161,000.00 $1,405,000.00 $306,000.00 $-148,000.00 -- -- --
Accumulated Deficit $-750,300,000.00 $-679,358,000.00 $-646,343,000.00 $-577,800,000.00 $-511,600,000.00 $-450,600,000.00 $-396,122,000.00 $-335,100,000.00 $-284,400,000.00 $-243,114,000.00 $-211,528,000.00 $-181,019,000.00 -- -- $-23,000.00
Total Stockholders' Equity $1,023,812,000.00 $1,069,779,000.00 $1,079,617,000.00 $1,118,731,000.00 $1,163,419,000.00 $606,519,000.00 $629,023,000.00 $619,716,000.00 $655,635,000.00 $681,228,000.00 $703,164,000.00 $-168,443,000.00 $-129,440,000.00 $-2,594,000.00 $-2,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $1,126,724,000.00 $1,179,044,000.00 $1,227,829,000.00 $1,222,500,000.00 $1,258,544,000.00 $688,523,000.00 $717,802,000.00 $695,544,000.00 $733,997,000.00 $749,369,000.00 $773,855,000.00 $435,235,000.00 -- -- --

Statement of Operations

Date 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $107,473,000.00 $55,183,000.00 $192,987,000.00 $140,759,000.00 $89,337,000.00 $42,042,000.00 $144,535,000.00 $95,172,000.00 $55,177,000.00 $23,403,000.00 $151,860,000.00 $133,356,000.00 $122,486,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $142,619,000.00 $71,546,000.00 $258,243,000.00 $188,881,000.00 $120,839,000.00 $57,683,000.00 $202,008,000.00 $137,433,000.00 $82,422,000.00 $36,461,000.00 $192,842,000.00 $159,796,000.00 $137,609,000.00 $2,597,000.00 $2,000.00
Loss from Operations $-104,230,000.00 $-33,201,000.00 $-258,243,000.00 $-188,881,000.00 $-120,839,000.00 $-57,683,000.00 $-64,575,000.00 $-55,011,000.00 $-45,961,000.00 $-36,461,000.00 $-192,842,000.00 $-159,796,000.00 $135,012,000.00 $2,597,000.00 $-2,000.00
Loss Before Income Taxes -- -- $-250,221,000.00 $-181,651,000.00 $-115,454,000.00 $-54,480,000.00 $-184,925,000.00 $-123,740,000.00 $-73,038,000.00 $-31,636,000.00 $-211,622,000.00 $-180,996,000.00 $-137,499,000.00 $-2,597,000.00 $-2,000.00
Earnings Per Share Basic $-0.78 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 133,503,262 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.78 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 133,503,262 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 101,000,000 -- -- 47,250,000
Common Stock Shares Outstanding 142,120,731 141,470,075 140,474,305 139,755,839 139,233,450 125,262,537 124,267,358 121,895,479 121,631,278 121,527,320 121,482,671 31,270,573 -- -- 26,249,993
Common Stock Value $142,000.00 $141,000.00 $140,000.00 $140,000.00 $139,000.00 $125,000.00 $124,000.00 $122,000.00 $122,000.00 $121,000.00 $121,000.00 $31,000.00 -- -- $26,000.00
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2021 PursePoor.com